Ely Benaim, Chief Medical Officer at NovoCure Ltd (NVCR), sold 437 shares at $69.66 ($30K) on 2022-08-02, disclosed to the SEC on 2022-08-03.
Seasonal sale ($30k) by Chief Medical Officer — this insider has traded NVCR in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| NVCR | SELL | 2022-03-07 | $332K | — | Filing → |
| NVCR | SELL | 2021-08-04 | $139K | — | Filing → |
| NVCR | SELL | 2021-08-03 | $367K | — | Filing → |